These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy. Genazzani AR; Gadducci A; Gambacciani M Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941 [TBL] [Abstract][Full Text] [Related]
6. Review of epidemiologic studies of endometrial cancer and exogenous estrogen. Cramer DW; Knapp RC Obstet Gynecol; 1979 Oct; 54(4):521-6. PubMed ID: 492641 [TBL] [Abstract][Full Text] [Related]
7. Cancer and the use of estrogens. Gambrell RD Int J Fertil; 1986; 31(2):112-3, 116-22. PubMed ID: 2875032 [TBL] [Abstract][Full Text] [Related]
8. Update on estrogens and uterine cancer. FDA Drug Bull; 1979; 9(1):2-3. PubMed ID: 428701 [TBL] [Abstract][Full Text] [Related]
10. Decreased incidence of breast cancer in postmenopausal estrogen-progestogen users. Gambrell RD; Maier RC; Sanders BI Obstet Gynecol; 1983 Oct; 62(4):435-43. PubMed ID: 6888821 [TBL] [Abstract][Full Text] [Related]
11. Exogenous estrogens and development of breast and endometrial cancer. Vakil DV; Morgan RW; Halliday M Cancer Detect Prev; 1983; 6(4-5):415-24. PubMed ID: 6652636 [TBL] [Abstract][Full Text] [Related]
12. Risks and benefits of long-term treatment with estrogens. Mack TM; Ross RK Schweiz Med Wochenschr; 1989 Dec; 119(50):1811-20. PubMed ID: 2692147 [TBL] [Abstract][Full Text] [Related]
13. Endometrial cancer after menopausal use of estrogens. Greenwald P; Caputo TA; Wolfgang PE Obstet Gynecol; 1977 Aug; 50(2):239-43. PubMed ID: 876565 [TBL] [Abstract][Full Text] [Related]
14. Editorial: Cancer risk and estrogen use in the menopause. Ryan KJ N Engl J Med; 1975 Dec; 293(23):1199-200. PubMed ID: 1186792 [TBL] [Abstract][Full Text] [Related]
15. Epidemiologic aspects of exogenous progestagens in relation to their role in pathogenesis of human breast cancer. van Leeuwen FE Acta Endocrinol (Copenh); 1991; 125 Suppl 1():13-26. PubMed ID: 1801500 [TBL] [Abstract][Full Text] [Related]
16. The adverse effects of hormonal therapy. Bush TL Cardiol Clin; 1986 Feb; 4(1):145-52. PubMed ID: 3518931 [TBL] [Abstract][Full Text] [Related]
17. Editorial: Risks and benefits of estrogen use. Weiss NS N Engl J Med; 1975 Dec; 293(23):1200-2. PubMed ID: 1186793 [TBL] [Abstract][Full Text] [Related]
18. Estrogen use and postmenopausal women: a basis for informed decisions. NIH Consensus Development. Gastel B; Cornoni-Huntley J; Brody JA J Fam Pract; 1980 Nov; 11(6):851-60. PubMed ID: 7005387 [TBL] [Abstract][Full Text] [Related]
19. Exogenous estrogens and other factors in the epidemiology of breast cancer. Kelsey JL; Fischer DB; Holford TR; LiVoisi VA; Mostow ED; Goldenberg IS; White C J Natl Cancer Inst; 1981 Aug; 67(2):327-33. PubMed ID: 6943372 [TBL] [Abstract][Full Text] [Related]
20. Sex steroids and cancer. Gambrell RD Obstet Gynecol Clin North Am; 1987 Mar; 14(1):191-206. PubMed ID: 3306519 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]